ESPB vs iPACK+ACB in Total Knee Arthroplasty

Conditions: Knee Arthritis; Knee Arthropathy; Knee Osteoarthritis; Knee Pain Chronic; Knee Disease; Knee Rheumatism Interventions: Drug: Ropivacaine 0.2% Injectable Solution; Drug: Ropivacaine 0.2% Injectable Solution; Drug: control group Sponsors: Poznan University of Medical Sciences Not yet recruiting

https://clinicaltrials.gov/study/NCT06302218

Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials